Conference
The Third Annual DC Engage Harm Reduction Conference
The DC Engage annual Harm Reduction Conference brings together harm reductionists, community members, and experts to discuss the latest practices, techniques, and important issues in the harm reduction community.
DC Health and HealthHIV held the third annual DC Harm Reduction Conference on Thursday, April 11, 2024 at the Gallaudet University Kellogg Center in Washington, DC. The purpose of this day-long, in-person conference is to engage clinicians, service providers, and community members in harm reduction prevention, treatment, and recovery strategies.
The conference is free to attend and some of the sessions will include free continuing education credits.
Archived Conference Sessions
-
Nutrition for Pain Management
This module reviews the impact of diet and chronic illness on pain. It assists providers by improving their ability to discuss various evidence-based diets that can help to alleviate pain.
-
Opioid Overdose Prevention & Naloxone Education for Community
This module is intended for public use. By completing this module, learners will be able to utilize nasal naloxone to reverse a known overdose in emergency situations. Learners will understand how nasal naloxone reverses an overdose and will be able to summarize the epidemiology of opioid overdoses in the District of Columbia.
-
Opportunities and Challenges of U=U
This webinar will review challenges involved in achieving viral suppression and maintaining undetectable viral loads, particularly for people who use drugs. Providers also will gain an understanding of potential opportunities for promoting activities that contribute to harm reduction strategies in order to reduce barriers and increase drug user health.
-
Patient-Provider Relationship in Addressing Addiction
This module details effective patient-provider communication in addressing opioid use, misuse, and abuse. It identifies and describes models of communication, applying relevant content to the process of addressing opioid use disorders and the concern of stigma in clinical practice.